Information on this blog is being shared only for the purpose of creating legal awareness in public at large, especially in the field of Intellectual Property Right. As there may be possibility of error, omission or mistake in legal interpretation on the contents of this blog, it should not be treated as substitute for legal advise.
Saturday, February 28, 2026
Godrej Consumer Vs Reckitt Benckiser:DB
Friday, February 27, 2026
Mountain Valley Springs India Private Limited Vs Baby Forest Ayurveda Private Limited
Mountain Valley Springs India Private Limited, operating under the brand Forest Essentials, has been selling Ayurvedic products since 2000 with significant sales and registrations for the mark Forest Essentials across various classes, including baby care products under sub-marks like Forest Essentials Baby since 2006.
In June 2023, they discovered Baby Forest Ayurveda Private Limited using the marks Baby Forest and Baby Forest-Soham of Ayurveda for similar baby Ayurvedic products, alleging deceptive similarity, customer confusion evidenced by social media queries and Google suggestions, and malicious copying including rebranding and store location choices.
The respondents, formerly Landsmill Healthcare, registered Baby Forest in 2020 on a proposed use basis, started sales in 2022 with notable revenue, and argued no similarity, that Forest is a generic dictionary word with no monopoly, their focus is exclusively on baby products unlike the appellant's adult-targeted range, and trade dress plus logos differ.
Forest Essentials filed a commercial suit CS(COMM) 523/2023 for trademark infringement and passing off, seeking interim injunction under Order XXXIX Rules 1 and 2 CPC.
The single judge dismissed the applications on May 15, 2024, reasoning that the appellant failed to prove proprietorship over baby-specific sub-marks which were marketed under the main house mark, Forest is generic and not registered separately under Section 17(2) of the Trade Marks Act 1999, the composite mark Forest Essentials cannot be dissected for monopoly over Forest, no visual phonetic or structural similarity exists between the marks, trade dress packaging and tree logos are dissimilar, the respondents' concession to stop using Saundarya and Baby Essentials was a goodwill gesture not an admission, and evidence like isolated social media posts or Google predictions does not show widespread confusion.
The appellant appealed this denial in FAO(OS)(COMM) 111/2024. The division bench, after considering arguments, upheld the single judge's findings, emphasizing that without secondary meaning the common word Forest cannot be monopolized, the marks are distinct when viewed as wholes under the anti-dissection rule, no prima facie case for infringement or passing off, balance of convenience favors the registered user respondents, and no irreparable harm, thus refusing interim relief. The court dismissed the appeal, allowing the respondents to continue using the challenged marks pending trial.
Mountain Valley Springs India Pvt.Ltd. Vs. Baby Forest Ayurveda Pvt.Ltd. 27.02.2026, FAO(OS)(COMM) 111/2024, 2026:DHC:1756-DB: DHC, Navin Chawla , Madhu Jain .
Disclaimer: Readers are advised not to treat this as substitute for legal advise as it may contain errors in perception, interpretation, and presentation.
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
#IPUpdate #IPCaselaw #IPCaseLaw #IPLaw #IPRNews #IPIndiaupdate #Trademark #Copyright #DesignLaw #PatentLaw #Law #Legal #IndianIPUpdate #AdvocateAjayAmitabhSuman #IPAdjutor
Thursday, February 26, 2026
Reckitt Benckiser Vs Godrej Consumer Products Limited
Mangrol Oil Mill Vs Vikas Oil Industries
Wednesday, February 25, 2026
Landmark Crafts Limited Vs. Romil Gupta
Later, the appellant, Landmark Crafts Limited, challenged the registration on the ground that the change was substantial and that proper user documents had not been filed for the amended mark. The core dispute was whether this stylistic adjustment was a minor clerical correction or a major change that required fresh examination and fresh proof of use.
On the merits, the Bench agreed with the Single Judge that the change in the mark was not substantial. The Court observed that the four letters remained the same, the relative sizes stayed identical, and only the orientation of the two smaller letters was adjusted. Applying the ordinary meaning of “substantial” as something essential or of real importance, the judges found that this was a minor stylistic correction rather than a complete transformation of the mark. Because the alteration was not substantial, there was no need for the applicant to file a fresh user affidavit. The original claim of use continued to apply to the corrected mark.
The Court also noted that the rectification proceedings filed separately by the appellant remain unaffected, so the appellant’s rights to challenge the user claim or other aspects are fully preserved. In the end, the Division Bench dismissed the appeal and restored the registration, while reiterating that its observations would not influence the pending rectification petition.
Suggested Titles for the Article
- Delhi High Court Holds Minor Stylistic Change in Device Mark is Not Substantial Alteration
- Landmark Ruling on Trademark Amendments: Clarity on “Substantial Alteration” under Rule 37
- No Fresh User Affidavit Needed for Minor Correction in Trademark: Delhi HC
- Procedural Fairness and Trademark Law: Delhi High Court Restores Registration after Cancellation on Technical Grounds
=====
The respondent applied for registration of a stylized device mark for self-tapping screws claiming use since 2013. During examination, he sought a small correction in the positioning of two letters in the mark, which the Trade Marks Registry allowed and the mark was registered. The appellant challenged the registration alleging the change was substantial. Acting on its own motion, the Deputy Registrar cancelled the registration. The Single Judge set aside the cancellation order holding that mandatory notice period was not followed and that the change was not substantial. In Letters Patent Appeal, the Division Bench upheld the Single Judge’s decision, restored the registration and dismissed the appeal, while clarifying that the appellant’s separate rectification petition remains unaffected.
Points of Law Settled
- The one-month notice requirement prescribed under Rule 100(1) of the Trade Marks Rules, 2017 for suo motu rectification under Section 57(4) is mandatory; breach of this requirement renders the cancellation order invalid irrespective of prejudice or waiver. (Landmark Crafts Limited v. Romil Gupta Trading as Sohan Lal Gupta & Anr., LPA 575/2025, Paras 42-44)
- A minor stylistic or positional change in a device mark which does not alter its essential identity or overall commercial impression does not amount to “substantial alteration” under the proviso to Rule 37 of the Trade Marks Rules, 2017. (Landmark Crafts Limited v. Romil Gupta Trading as Sohan Lal Gupta & Anr., LPA 575/2025, Paras 50, 62)
- When an amendment to a trademark is not substantial, no fresh statement of user or affidavit is required; the original user claim continues to apply to the corrected mark. (Landmark Crafts Limited v. Romil Gupta Trading as Sohan Lal Gupta & Anr., LPA 575/2025, Paras 57-61)
Case Title: Landmark Crafts Limited v. Romil Gupta:25.02.2026:LPA 575/2025:2026:DHC:1674-DB:C. Hari Shankar & Om Prakash Shukla
=====
Tuesday, February 24, 2026
Sana Herbals Private Limited Vs Mohsin Dehlvi-DB
AR Rahman Vs Ustad Faiyaz Wasifuddin Sagar
Harshad Chiman Lal Modi Vs DLF Universal Limited
Boehringer Ingepheim GMBH Vs Controller of Patent-DB
Maintainability of Patent Revocation , post expiry of Patent
Introduction
This judgment, delivered on 24 February 2026 by a Division Bench of the High Court of Delhi in LPA 129/2025 (with CM APPL. 10551/2025), arises from an appeal filed by Boehringer Ingelheim Pharma GMBH and Co KG (“Boehringer”) against the judgment dated 15 January 2025 passed by a learned Single Judge of the same Court in CO (COMM IPD-PAT) 38/2022.
The Division Bench has answered both questions in the affirmative (i.e., revocation petitions remain maintainable in both scenarios), thereby upholding the Single Judge’s order dismissing Boehringer’s applications for dismissal of Macleods Pharmaceuticals Limited’s (“Macleods”) revocation petition. The judgment is noteworthy for its exhaustive statutory interpretation, reliance on international comparative law (particularly UK and European patent principles), detailed contextual analysis of the Ayyangar Committee Report, and clarification of the interplay between revocation (Section 64), invalidity defence (Section 107), and related provisions. It settles important legal concepts regarding the retrospective (ab initio) nature of revocation, the in rem effect of revocation orders, the independent nature of revocation as a standalone remedy, and the distinction between revocation and a mere defensive plea of invalidity.
Factual Background
Indian Patent No. IN 243301 (“IN’301”), granted to Boehringer on 5 October 2022 with a priority date of 21 August 2002, covers the pharmaceutical compound Linagliptin (used in diabetes treatment).
On 17 February 2022 (i.e., even before grant, but after publication), Macleods filed CO (COMM IPD-PAT) 38/2022 in the Delhi High Court under Section 64(1) seeking revocation of IN’301 on various grounds (including lack of novelty, inventive step, etc.).
Two days later, on 19 February 2022, Boehringer instituted COMS 3/2022 before the High Court of Himachal Pradesh (“the Himachal suit”) alleging that Macleods’ products infringed IN’301 and seeking permanent injunction, damages, and other reliefs. In its written statement in the Himachal suit, Macleods raised the defence of invalidity of IN’301 under Section 107(1) of the Act.
IN’301 expired by efflux of time on 18 August 2023 (20-year term from priority date). Boehringer, however, continues to press its claim for damages/account of profits in the Himachal suit for alleged past infringements during the patent’s life. Macleods’ revocation petition remained pending in Delhi.
Procedural Background
Macleods’ revocation petition (CO (COMM IPD-PAT) 38/2022) was filed in Delhi. Boehringer filed two applications in that petition:
- IA 7635/2024: Seeking dismissal on the ground that the patent had expired (Issue (ii)).
- IA 46685/2024: Seeking dismissal on the ground that Macleods had already taken a Section 107 invalidity defence in the Himachal suit (Issue (i)).
The learned Single Judge, by judgment dated 15 January 2025, dismissed both IAs, holding that the revocation petition was maintainable and could continue despite both the expiry of the patent and the raising of the Section 107 defence. Aggrieved, Boehringer preferred the present Letters Patent Appeal (LPA 129/2025). The Division Bench heard detailed arguments from Dr. Abhishek Manu Singhvi and Mr. Prashanto Chandra Sen (for Boehringer), Mr. G. Nataraj (for Macleods), and Ms. Swathi Sukumar, Sr. Adv. (Amicus Curiae). Written submissions were also filed. The appeal was reserved on 26 November 2025 and pronounced on 24 February 2026.
Dispute in Question
The core dispute crystallises into the two pure questions of law extracted in para 1 of the judgment (reproduced above). These questions are fact-agnostic but arose in the specific factual matrix of IN’301. The questions directly engage the statutory scheme of the Patents Act concerning:
- The nature and effect of revocation under Section 64 (standalone petition or counter-claim).
- The distinct character of an invalidity defence under Section 107(1) in an infringement suit.
- The continued legal existence and enforceability of a “patent” even after expiry.
- The concept of “person interested” under Section 2(1)(t) read with Section 64.
- Whether revocation operates retrospectively (ab initio) or only prospectively.
The resolution of these questions has profound implications for patent litigation strategy, multiplicity of proceedings, in rem vs in personam effects, and the survival of causes of action post-expiry (especially damages claims).
Arguments of Parties
Boehringer’s Arguments
- Revocation presupposes a “live” patent; once expired, there is nothing left to revoke (concept of revocation inherently requires the patent to be alive).
- Post-expiry, the petitioner ceases to be a “person interested” under Section 2(1)(t) because no monopoly or threat remains (relied on Dr. Reddys Laboratories Ltd v. Controller of Patents).
- Allowing revocation after expiry would be an academic exercise with no legal consequence (no retrospective effect).
- A Section 107 defence in the Himachal suit bars a parallel revocation petition because both seek the same ultimate relief (invalidity); continuing both would cause conflicting judgments across High Courts and multiplicity (relied on para 26 of Aloys Wobben v. Yogesh Mehra).
- A Section 107 defence is essentially in the nature of a counter-claim; once raised, the defendant must pursue revocation only via counter-claim in the suit (relied on Unilin Beheer B.V. v. Balaji Action Buildwell and Ramesh Chand Ardawatiya v. Anil Panjwani).
- Revocation and invalidity defence are not qualitatively different; both lead to the same practical outcome.
Macleods’ Arguments
- Section 64 uses the word “patent” (defined under Section 2(1)(m) as a patent granted under the Act) and not “patent in force”; expiry does not efface the patent’s character (no casus omissus).
- Revocation operates ab initio (retrospectively from grant date), effacing the patent as if it never existed; hence, a live cause of action survives even post-expiry (especially to defeat the patentee’s damages claim).
- Section 107 defence and revocation are fundamentally different: the former is in personam (defence in suit, at best declaratory, entered only in supplemental record under Section 151(2)), while the latter is in rem (removes patent from register entirely under Section 151(1)).
- A defendant may raise Section 107 defence and pursue revocation (via petition or counter-claim), but not both petition and counter-claim simultaneously (Aloys Wobben correctly read).
- Standalone right under Section 64 is not extinguished by expiry; patentee’s damages claim under Section 108 survives, so defendant’s right to revoke must also survive (relied on Ayyangar Committee Report paras 284–291).
- “Person interested” status continues because Macleods remains a defendant facing damages and has interest in manufacturing/sale.
Amicus Curiae
- Endorsed Macleods’ view; emphasised distinct statutory mechanisms (pre/post-grant opposition, revocation, Section 107, compulsory licensing) and retrospective effect of revocation. Relied on Ayyangar Report, Ajay Industrial Corporation, Girdhari Lal Gupta, and Section 108.
Reasoning of the Judge (Including Different Provisions of Law and Their Context)
The Division Bench’s reasoning is structured, statutory, and comparative. It first addresses the retrospective nature of revocation under Section 64.
Key Provisions and Their Contextual Interpretation
- Section 64(1): “Subject to the provisions contained in this Act, a patent … may be revoked on a petition of any person interested or of the Central Government or on a counter-claim in a suit for infringement of the patent by the High Court on any of the following grounds…”
- Context: “Patent” is not qualified by “in force”. The disjunctive “or” treats revocation petition and counter-claim at par. Grounds (lack of novelty, obviousness, insufficiency, etc.) go to the root of the grant itself → revocation must operate ab initio.
- Section 2(1)(m): Defines “patent” as “a patent for any invention granted under this Act”. Once granted, it remains a “patent” even after expiry; expiry only renders it unenforceable prospectively.
- Section 2(1)(t): “Person interested” includes a person engaged in/promoting research in the same field. Macleods, being a defendant facing damages, retains interest post-expiry.
- Section 107(1): Provides that in an infringement suit, every ground on which revocation may be sought under Section 64 is available as a defence.
- Context: Purely defensive, in personam, operates only between parties; does not remove patent from register.
- Section 151: Mandates transmission of High Court orders. Sub-section (1) (revocation) → entry in Register (effaces patent). Sub-section (2) (Section 107 finding) → entry only in supplemental record (declaratory). Clear statutory distinction.
- Section 53(4): On expiry, subject-matter not entitled to protection (affects patentee’s right to sue, not third-party right to revoke).
- Section 71: Rectification of register (separate remedy).
- Section 58 & 114: Amendment and relief for partially valid specification (available in revocation but limited in Section 107 suits).
- Ayyangar Committee Report (paras 284–291): Explains legislative intent — revocation is in rem, affects register; Section 107 is inter partes only. Supplemental record for infringement findings to inform public without effacing patent.
Core Legal Concepts Cleared
- Retrospective effect of revocation: Revocation under Section 64 operates ab initio (from date of grant), rendering the patent void as if never granted. This is not expressly stated but flows from: (a) grounds attacking the grant itself; (b) equivalence of petition and counter-claim; (c) in rem nature; (d) international alignment.
- “Patent” vs “patent in force”: Statutory definition controls; expiry does not denude the patent of its character.
- Distinction between revocation and Section 107 defence: Revocation effaces the patent entirely (in rem); Section 107 is defensive and in personam. They can co-exist.
- Survival post-expiry: Patentee’s damages claim (Section 108) survives; symmetrically, defendant’s revocation right survives to defeat that claim.
Judgements Including Their Citation and Context Relied by Judge in Reasoning
- Aloys Wobben v. Yogesh Mehra (2014) 15 SCC 360: Heavily relied upon by both sides. The Court reads it contextually — para 26 does not lay down an absolute bar on revocation petitions after suit filing; it applies only where a counter-claim has already been filed (res judicata). Where only Section 107 defence is raised (as here), revocation petition remains maintainable. Paras 25, 26, 27.2 clarify the harmonious reading of Section 64.
- Virgin Atlantic Airways Ltd v. Zodiac Seats UK Ltd [2013] UKSC 46 (UK Supreme Court): Landmark comparative authority. Held that revocation of a patent (under UKPA/EPC) operates retrospectively from grant date; patent treated as never having existed. Applied because Indian statutory scheme (Section 64 + definition of patent) mirrors UK/EPC position. Key passages (Lord Sumption & Lord Neuberger) on in rem effect and policy of Patents Act.
- Ajay Industrial Corporation v. Shiro Kanao of Ibaraki City AIR 1983 Del 496 (DB): Relied on for post-expiry revocation being permissible; transmission to Controller not futile.
- Star Textile Engineering Works Ltd v. James Mackie Holding Ltd 1977 SCC OnLine Cal 280: Cited for proposition that expiry does not bar revocation.
- Dr. Reddys Laboratories Ltd v. Controller of Patents (Single Judge): Distinguished; does not hold that “person interested” ceases post-expiry when damages claim survives.
- Unilin Beheer B.V. v. Balaji Action Buildwell (2018) 76 PTC 194: Distinguished on facts; does not equate Section 107 defence to counter-claim.
- Ramesh Chand Ardawatiya v. Anil Panjwani (2003) 7 SCC 350: Distinguished; not applicable to patent-specific statutory scheme.
- Bishwanath Prasad Radhey Shyam v. Hindustan Metal Industries (1979) 2 SCC 511: On limited nature of grant (used in rejoinder).
Final Decision
The Division Bench dismissed Boehringer’s LPA 129/2025 with no order as to costs. It fully agreed with the Single Judge. Both issues were answered in favour of maintainability of the revocation petition. The revocation petition filed by Macleods can proceed and be adjudicated on merits even after (a) raising Section 107 defence in the Himachal suit, and (b) expiry of IN’301.
Concluding Note
The judgment is a masterclass in statutory interpretation that harmonises the Patents Act’s provisions with legislative intent (Ayyangar Report), practical realities of patent litigation, and international best practices. It rejects hyper-technical attempts to extinguish revocation rights post-expiry or after a defensive plea, emphasising that revocation is a powerful in rem remedy that operates retrospectively to clear the register of invalid grants. By doing so, it safeguards public interest in invalid patents not being used to extract damages or restrain legitimate competition even after expiry.
Legal Points Settled in This Case (Key Takeaways for Patent Law)
- Revocation under Section 64 operates retrospectively (ab initio): If successful, the patent is deemed never to have been granted. It effaces the patent from the register as if the grant was void from inception.
- A “patent” continues to exist for Section 64 purposes even after expiry: The statutory definition (Section 2(1)(m)) is not limited to “patent in force”. Expiry only affects prospective enforceability.
- “Person interested” status survives patent expiry: So long as the petitioner has a real interest (e.g., facing a damages claim), it remains entitled to maintain revocation.
- Section 107 invalidity defence and Section 64 revocation are independent and co-exist: A defendant may raise both; Section 107 is merely defensive (in personam), while revocation is in rem and removes the patent entirely. Only a counter-claim and revocation petition cannot be pursued simultaneously (per Aloys Wobben).
- No multiplicity or conflict issue: The two proceedings operate in different legal spheres; a Section 107 finding does not bar revocation (different consequences under Section 151).
- Damages claim survival is symmetrical: Patentee’s right to past damages (Section 108) survives expiry; defendant’s right to revoke (to defeat that claim) also survives.
- Indian law aligns with UK/EPC on retrospective revocation: Virgin Atlantic principles are persuasive and applicable.
Monday, February 23, 2026
Fertin Pharma Vs Assistant Controller of Patent
Life Insurance Corporation of India Vs Sanjeev Builders
The Court clarified that Order 2 Rule 2 CPC, which bars a subsequent suit for a relief that could have been claimed earlier, has no application to an amendment sought in an already pending suit. It also held that the principle of constructive res judicata was not attracted because there was no earlier adjudication on merits.
Referring to the Specific Relief Act, the Court noted that the law itself contemplates amendment of the plaint at any stage to include a claim for compensation. The previous judgment of the Supreme Court between the same parties (on impleadment of an assignee) was distinguished on facts and held not applicable to the present case.
The Supreme Court ultimately dismissed LIC’s appeal, upheld the orders of the High Court permitting the amendment, and directed that the issue of limitation shall be decided during the trial on merits. The amendment was allowed so that the plaintiffs could claim enhanced damages without forcing them to file a fresh suit, thereby avoiding multiplicity of litigation.
- Courts must be extremely liberal in allowing amendments if they help in deciding the real dispute and no irreparable prejudice is caused to the other side.
- Delay by itself is not a ground to reject an amendment application, especially when the suit has not yet reached the stage of trial.
- Order 2 Rule 2 CPC does not apply to amendments sought in an existing suit.
- The provisos to Sections 21(5) and 22(2) of the Specific Relief Act expressly permit amendment of the plaint at any stage to include or enhance a claim for compensation.
- Even where a fresh suit on the amended claim might appear barred by limitation, the court can still allow the amendment if it serves the ends of justice, leaving the limitation issue to be decided at trial.
- An amendment relating only to the quantum of relief based on facts already pleaded in the plaint does not change the nature of the suit and should ordinarily be allowed.
- Where the amendment is sought before commencement of trial, the court should be more liberal because the opposite party will have full opportunity to meet the amended case.
- The court may direct that the amendment shall not relate back to the date of the original suit if it is necessary to protect any right accrued to the defendant by lapse of time.
Suggested Titles for the Article
- Supreme Court Allows Enhancement of Damages Claim in Specific Performance Suit After 31 Years
- Liberal Amendment of Pleadings: Key Principles Laid Down by Supreme Court in LIC Case
- Delay No Bar to Amendment: Supreme Court Permits Higher Damages Claim in Pending Suit
- Order 2 Rule 2 CPC Does Not Apply to Amendments – Landmark Supreme Court Ruling
=====
Sanjeev Builders filed a 1986 suit against LIC seeking specific performance of an agreement to sell property and claimed alternative damages. After many years of pendency, they applied to amend the plaint to substantially increase the damages amount citing rise in property value and delay in the case. The Single Judge allowed the amendment keeping the question of limitation open for trial and permitted LIC to file additional written statement. The Division Bench of the Bombay High Court affirmed the order. LIC challenged it before the Supreme Court on grounds of delay, limitation, Order 2 Rule 2 CPC and constructive res judicata. The Supreme Court dismissed the appeal and upheld the amendment.
• Order 2 Rule 2 CPC has no application to an amendment sought in an already pending suit. (Paras 51 & 71.1)
• Mere delay in filing amendment application is not a ground for rejection; the court may allow it and frame limitation as a separate issue for trial. (Paras 71.9 & 32)
• In a suit for specific performance, amendment to enhance the claim for compensation in addition to or in substitution of specific performance is permissible at any stage under the provisos to Sections 21(5) and 22(2) of the Specific Relief Act, 1963. (Paras 65-67)
• Amendment relating only to the quantum of relief based on facts already pleaded in the plaint does not change the nature of the suit and is ordinarily allowed. (Para 71.10)
=====
Blog Archive
- March 2026 (38)
- February 2026 (44)
- January 2026 (80)
- December 2025 (108)
- November 2025 (62)
- October 2025 (44)
- September 2025 (75)
- August 2025 (103)
- July 2025 (95)
- June 2025 (93)
- May 2025 (118)
- April 2025 (91)
- March 2025 (148)
- February 2025 (116)
- January 2025 (58)
- October 2024 (8)
- September 2024 (34)
- August 2024 (68)
- July 2024 (39)
- June 2024 (57)
- May 2024 (49)
- April 2024 (6)
- March 2024 (44)
- February 2024 (39)
- January 2024 (21)
- December 2023 (29)
- November 2023 (23)
- October 2023 (27)
- September 2023 (33)
- August 2023 (29)
- July 2023 (29)
- June 2023 (2)
- May 2023 (1)
- April 2023 (5)
- March 2023 (6)
- February 2023 (1)
- November 2022 (17)
- October 2022 (11)
- September 2022 (30)
- August 2022 (46)
- July 2022 (36)
- June 2022 (26)
- October 2020 (1)
- September 2020 (1)
- April 2020 (1)
- March 2020 (1)
- February 2020 (2)
- December 2019 (1)
- September 2019 (3)
- August 2019 (2)
- July 2019 (1)
- June 2019 (2)
- April 2019 (3)
- March 2019 (2)
- February 2019 (2)
- January 2019 (2)
- December 2018 (3)
- November 2018 (1)
- October 2018 (2)
- September 2018 (2)
- August 2018 (8)
- July 2018 (2)
- June 2018 (1)
- May 2018 (41)
- April 2018 (7)
- March 2018 (3)
- February 2018 (4)
- January 2018 (2)
- December 2017 (6)
- November 2017 (4)
- September 2017 (5)
- August 2017 (6)
- July 2017 (1)
- June 2017 (1)
- May 2017 (10)
- April 2017 (16)
- November 2016 (3)
- October 2016 (24)
- March 2015 (2)
- January 2014 (1)
- December 2013 (4)
- October 2013 (2)
- September 2013 (7)
- August 2013 (27)
- May 2013 (7)
- September 2012 (31)
- December 2009 (3)
- September 2009 (1)
- March 2009 (3)
- January 2009 (2)
- December 2008 (1)
Featured Post
WHETHER THE REGISTRAR OF TRADEMARK IS REQUIRED TO BE SUMMONED IN A CIVIL SUIT TRIAL PROCEEDING
WHETHER THE REGISTRAR OF TRADEMARK IS REQUIRED TO BE SUMMONED IN A CIVIL SUIT TRIAL PROCEEDING IN ORDER TO PROVE THE TRADEMARK REGISTRA...
-
A Party is not allowed to argue a case, what is not pleaded. Introduction: This case revolves around a fundamental principle of civil proce...
-
Species patents following a Markush patent must demonstrate a distinct inventive step Introduction The AstraZeneca AB & Anr. Vs. Intas ...
My Blog List
-
आत्माओं का संसार - यह खोरशेद भावनागरी की पुस्तक "द लॉज़ ऑफ़ द स्पिरिट वर्ल्ड" पर आधारित है, जो उनके दिवंगत बेटों द्वारा संचारित दिव्य संदेशों का संग्रह है। इसमें आत्मा जगत ...1 day ago
-
IPL:Spice In, Nationality Out - I was sitting in my office. It was a hot afternoon. The fan was running slowly and making strange sounds like an old typewriter. Files were lying on my d...11 months ago
-
-
My other Blogging Links
- Ajay Amitabh Suman's Poem and Stories
- Facebook-My Judgments
- Katha Kavita
- Lawyers Club India Articles
- My Indian Kanoon Judgments
- Linkedin Articles
- Speaking Tree
- You Tube-Legal Discussion
- बेनाम कोहड़ा बाजारी -Facebook
- बेनाम कोहड़ा बाजारी -वर्ड प्रेस
- बेनाम कोहड़ा बाजारी-दैनिक जागरण
- बेनाम कोहड़ा बाजारी-नवभारत टाइम्स
- बेनाम कोहड़ा बाजारी-ब्लॉग स्पॉट
- बेनाम कोहड़ा बाजारी-स्पीकिंग ट्री